BACKGROUND/AIMS: Depression is highly prevalent in individuals with advanced kidney disease, but is less well studied in individuals with milder disease. We evaluated the association between kidney function and depression in the Health, Aging and Body Composition (Health ABC) study. METHODS: The study enrolled 3,075 community-dwelling black and white adults aged 70-79 years. Kidney function was measured by cystatin C and estimated glomerular filtration rate (eGFR). The main outcome was incident treated depression. RESULTS: 52% of participants had low (≤1.0), 33% intermediate (>1-1.25) and 15% high cystatin C (>1.25). Kidney function and depression were not associated at baseline. Of 2,731 nondepressed participants at baseline, 95 developed incident depression during follow-up. In unadjusted Cox proportional hazard models, hazard ratios (HR) for incident depression were 1.89 (95% confidence interval (CI) 1.21-2.97) for the intermediate and 2.17 (CI 1.24-3.79) for the high cystatin C group. Intermediate (HR = 1.84) and high (HR = 2.1) serum cystatin C remained associated with incident depression in adjusted models. Chronic kidney disease, defined by an eGFR <60 ml/min/1.73 m(2), was not associated with depression. CONCLUSION: Participants with higher cystatin C had an increased likelihood of developing treated depression. Future studies should target this high-risk group.
BACKGROUND/AIMS: Depression is highly prevalent in individuals with advanced kidney disease, but is less well studied in individuals with milder disease. We evaluated the association between kidney function and depression in the Health, Aging and Body Composition (Health ABC) study. METHODS: The study enrolled 3,075 community-dwelling black and white adults aged 70-79 years. Kidney function was measured by cystatin C and estimated glomerular filtration rate (eGFR). The main outcome was incident treated depression. RESULTS: 52% of participants had low (≤1.0), 33% intermediate (>1-1.25) and 15% high cystatin C (>1.25). Kidney function and depression were not associated at baseline. Of 2,731 nondepressed participants at baseline, 95 developed incident depression during follow-up. In unadjusted Cox proportional hazard models, hazard ratios (HR) for incident depression were 1.89 (95% confidence interval (CI) 1.21-2.97) for the intermediate and 2.17 (CI 1.24-3.79) for the high cystatin C group. Intermediate (HR = 1.84) and high (HR = 2.1) serum cystatin C remained associated with incident depression in adjusted models. Chronic kidney disease, defined by an eGFR <60 ml/min/1.73 m(2), was not associated with depression. CONCLUSION:Participants with higher cystatin C had an increased likelihood of developing treated depression. Future studies should target this high-risk group.
Authors: Linda F Fried; Ronit Katz; Mark J Sarnak; Michael G Shlipak; Paulo H M Chaves; Nancy Swords Jenny; Catherine Stehman-Breen; Dan Gillen; Anthony J Bleyer; Calvin Hirsch; David Siscovick; Anne B Newman Journal: J Am Soc Nephrol Date: 2005-10-26 Impact factor: 10.121
Authors: Jürgen Unützer; Michael Schoenbaum; Wayne J Katon; Ming-Yu Fan; Harold A Pincus; Diane Hogan; Jennifer Taylor Journal: J Am Geriatr Soc Date: 2009-01-16 Impact factor: 5.562
Authors: Jeffrey M Lyness; Moonseong Heo; Catherine J Datto; Thomas R Ten Have; Ira R Katz; Rebecca Drayer; Charles F Reynolds; George S Alexopoulos; Martha L Bruce Journal: Ann Intern Med Date: 2006-04-04 Impact factor: 25.391
Authors: S Susan Hedayati; Hayden B Bosworth; Libbie P Briley; Richard J Sloane; Carl F Pieper; Paul L Kimmel; Lynda A Szczech Journal: Kidney Int Date: 2008-06-25 Impact factor: 10.612
Authors: Kristine Yaffe; Karla Lindquist; Michael G Shlipak; Eleanor Simonsick; Linda Fried; Caterina Rosano; Suzanne Satterfield; Hal Atkinson; B Gwen Windham; Manjula Kurella-Tamura Journal: Ann Neurol Date: 2008-06 Impact factor: 10.422
Authors: Fabienne Dobbels; Melissa A Skeans; Jon J Snyder; Anne V Tuomari; J Ross Maclean; Bertram L Kasiske Journal: Am J Kidney Dis Date: 2008-03-20 Impact factor: 8.860
Authors: Andrea L Metti; Jane A Cauley; Hilsa N Ayonayon; Tamara B Harris; Caterina Rosano; Jeff D Williamson; Kristine Yaffe Journal: Alzheimer Dis Assoc Disord Date: 2013 Jul-Sep Impact factor: 2.703
Authors: Patrick J Brown; Melanie M Wall; Chen Chen; Morgan E Levine; Kristine Yaffe; Steven P Roose; Bret R Rutherford Journal: J Gerontol A Biol Sci Med Sci Date: 2018-09-11 Impact factor: 6.053
Authors: Nwamaka D Eneanya; Sarah L Goff; Talaya Martinez; Natalie Gutierrez; Jamie Klingensmith; John L Griffith; Casey Garvey; Jenny Kitsen; Michael J Germain; Lisa Marr; Joan Berzoff; Mark Unruh; Lewis M Cohen Journal: BMC Palliat Care Date: 2015-06-12 Impact factor: 3.234
Authors: Maria Grazia Morgese; Maria Bove; Lorenzo Di Cesare Mannelli; Stefania Schiavone; Anna Laura Colia; Stefania Dimonte; Emanuela Mhillaj; Vladyslav Sikora; Paolo Tucci; Carla Ghelardini; Luigia Trabace Journal: Front Pharmacol Date: 2022-01-03 Impact factor: 5.810